Logo Image
News|Videos|November 25, 2024

GLP-1 RA antiobesity medications: an introduction

Key Takeaways

  • GLP-1 receptor agonists are proving effective in reducing body mass index and enhancing patient health outcomes.
  • Patients are increasingly interested in understanding the benefits and mechanisms of these antiobesity medications.
SHOW MORE

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

The new GLP-1 RA antiobesity medications are showing excellent benefits for patient body mass index and health. Patients want to know more. Here’s an introduction with Robert Kushner, MD, has made a career as a researcher and author about overweight, obesity and nutrition. He’s also a doctor who has treated patients for years through Northwestern University’s Feinberg School of Medicine and Northwestern Medicine’s Center for Lifestyle Medicine.

Related Content

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update
Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

View more